Skip to main content
Top

Clinical and Translational Oncology

Issue 10/2016

Content (12 Articles)

Review Article

Signaling and molecular basis of bone marrow niche angiogenesis in leukemia

R. Shirzad, S. Shahrabi, A. Ahmadzadeh, K. R. Kampen, M. Shahjahani, N. Saki

Review Article

Role of taxanes in advanced prostate cancer

J. Cassinello, J. Carballido Rodríguez, L. Antón Aparicio

Research Article

Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics

L. Moreno, C. Linossi, I. Esteban, N. Gadea, E. Carrasco, S. Bonache, S. Gutiérrez-Enríquez, C. Cruz, O. Díez, J. Balmaña

Research Article

Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse

A. Orlandi, M. A. Calegari, M. Martini, A. Cocomazzi, C. Bagalà, G. Indellicati, V. Zurlo, M. Basso, A. Cassano, L. M. Larocca, C. Barone

Open Access Research Article

Ki-67 is a prognostic marker for hormone receptor positive tumors

M. E. Pérez-López, J. García-Gómez, M. T. Alves, A. Paradela, J. García-Mata, T. García-Caballero

Research Article

Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study

M. Trovo, N. Giaj-Levra, C. Furlan, M. T. Bortolin, E. Muraro, J. Polesel, E. Minatel, R. Tedeschi, A. R. Filippi, F. Alongi, U. Ricardi

Research Article

Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy

M. Rico, E. Martínez, S. Pellejero, B. Bermejo, P. Navarrete, M. Barrado, M. Campo, F. Mañeru, E. Villafranca, J. Aristu

Research Article

The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort

A. Gomez-Iturriaga, Á. Cabeza, J. Pastor, J. Jove, M. Casaña, A. G. Caamaño, J. Mengual, I. Henríquez, J. Muñoz, A. Hervás, C. G.-S. Segundo

Research Article

Long-term visual outcomes in intraocular retinoblastoma with eye preservation

A. Batra, N. Pushker, P. Venkatesh, T. Arora, R. Tewari, S. Bakhshi

Open Access Research Article

Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer

M. Nicoś, P. Krawczyk, B. Jarosz, M. Sawicki, M. Michnar, T. Trojanowski, J. Milanowski

Research Article

Clinical use of ipilimumab for metastatic melanoma in Spain: towards a more consistent approach

S. Martín-Algarra, L. de la Cruz-Merino, V. Soriano, J. L. Manzano, E. Espinosa

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine